Cerebrospinal cytokine levels in patients with acute depression

Neuropsychobiology

Volumn 40, Issue 4, 1999, Pages 171-176

  Levine, Joseph ^a,b   Barak, Y ^f   Chengappa, K N R ^b   Rapoport, A ^c   Rebey, M ^d   Barak, V ^e  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c WOLFSON MEDICAL CENTER   (Israel)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^f NONE

Author keywords

Cytokines; Depression; Interleukin 1; Interleukin 6; Psychoimmunology

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CYTOKINES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032718722     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026615     Document Type: Article

References (37)

1. Abbas AKA, Lichtman AH, Pober JS (eds): Cellular and Molecular Immunology, Philadelphia, Saunders, 1991, pp 227-236.
2. Campbell IL, Stalder AK, Chiang CS, Bellinger R, Heyser CJ, Steffensen S, Masliah E, Powell HC, Gold LH, Henriksen SJ, Siggins GR: Transgenic model to assess the pathogenesis actions of cytokines in the central nervous system. Mol Psychiatry 1997;2:125.
3. Dunn AJ: The role of interleukin 1 and tumor necrosis alpha in the neurochemical and neuroendocrine response to endotoxin. Brain Res Bull 1992;29:807-812.
4. Wang J, Dunn AJ: Cytokine effects on CNS biogenic amines. Neuroimmunomodutation 1995;22:319-328.
5. Kabiersch A, del Rey A, Honegger CG, Besedovsky HO: Interleukin-1 induces changes in norepinephrine metabolism in rat brain. Brain Behav Immun 1988;2:267-274.
6. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH: Cytokine specific central monoamine alterations induced by interleukin 1, 2, and 6. Brain Res 1994;643:40-49.
7. Dantzer R, Bluthe RM, Kent S, Goodall G: Behavioral effects of cytokines: An insight into mechanisms of sickness behavior, in Souza EB: Neurobiology of Cytokines (part B), vol 17: Methods in Neuroscience. New York Academic Press, 1993.
8. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci 1995;18:83-88.
9. Gatti S, Bartfai T: Induction of tumor necrosis-alpha mRNA in the brain after peripheral endotoxin treatment: Comparison with interleukin-1 family and IL-6. Brain Res 1993;624: 291-294.
10. Breder CD, Dinarello CA, Saper CB: Interleukin 1 innervation of the human hypothalamus. Science 1988;240:321-324.
11. Owen MJ, Nemeroff CB: Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991;4:425-473.
12. Sheline YI, Wang PW, Gado MH, Csernansky JC, Vannier MW: Hippocampal atrophy in recurrent depression. Proc Natl Acad Sci USA 1996;93:3908-3913.
13. Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E: Interleukin-1β: A putative mediator of HPA axis hyperactivity in major depression. Am J Psychiatry 1993;150:1189-1193.
14. Muller N, Ackenheil M: Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 1988; 22:1-33.
15. Jimerson DC: Neurotransmitter hypotheses of depression. Research update. Psychiatr Clin North Am 1984;7:563-573.
16. Banks WA, Kastin AJ: Measurement of transport of cytokines across the blood brain barrier, in Souza EB: Neurobiology of Cytokines (part A), vol 16: Methods in Neuroscience. New York, Academic Press, 1993.
17. Maes M: A review on the acute phase response in major depression. Rev Neurosci 1993;4: 407-416.
18. Connor TL, Leonard BE: Depression, stress and immunological activation: The role of cytokines in depressive disorders. Life Sci 1998; 7: 583-606.
19. Maes M, Vandoolaeghe E, Ranjan R, Bosman E, Bergman R, Desnyder R: Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J Affect Disord 1995;36:29-36.
20. Maes M, Bosmans E, Meltzer HY: Immunoendocrine aspects of major depression: Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 1995;245: 172-178.
21. Macs M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R: Increased plasma concentration of interleukin-6, soluble interleukin-6, soluble interleukin-2, and transferrin receptor in major depression. J Affect Disord 1995;34:305-309.
22. Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R: Increased serum interleukin-1 -receptor-antagonist concentrations in major depression. J Affect Disord 1995;36:29-36.
23. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K: Indicators of immune activation in major depression. Psychiatry Res 1996;64:161-167.
24. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H: Cytokine production and serum proteins in depression. Scand J Immunol 1995;41:534-538.
25. Levine J, Kurtzman L, Rapoport A, Zimmerman J, Bersudsky Y, Shapiro J, Belmakr RH, Agam G: CSF inositol does not predict antidepressant response to inositol. J Neural Transm 1997;103:1457-1462.
26. American Psychiatric Association: Diagnostic and Statistical Manual of Psychiatric Disorders, ed 3, revised. Washington, American Psychiatric Association, 1987.
27. Hadasi D, Scheinowitz E, Leibovitz E, Sclarovsky S, Eldar M, Barak V: Increased serum concentrations of interleukin 1β in patients with coronary artery disease. Heart 1996;76: 24-28.
28. Abramov D, Schenker JD, Levin A, Friedler S, Nisman B, Barak V: Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome (OHSS). Hum Reprod 1996;11: 1381-1386.
29. Barak V, Schwartz A, Kalickman I, Nisman B, Gurman G, Shoenfeld Y: Prevalence of hypophosphatemia in sepsis and infection: The role of cytokines. Am J Med 1998;104:40-47.
30. Maes M, Smith RS: Fatty acids, cytokines, and major depression (editorial). Biol Psychiatry 1998;43:313-314.
31. Rich SC, Nemeroff CB: Neurochemical alteration of serotoninergic neuronal systems in depression (review). J Clin Psychiatry 1992; 53(suppl):3-7.
32. Xia Z, DePiere JW, Nassberger L: Tricyclic antidepressants inhibit IL-6, IL-1 and TNF release in human blood monocytes and IL-2 and interferon in T cells. Immunopharmacology 1996;34:27-37.
33. Blum-Degen D, Müller T, Kunn W, Gerlach M, Przuntek H, Riederer P: Interleukin-1β and IL-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 1995;202:17-20.
34. Dantzer R: Cytokines and sickness behavior. Biol Psychiatry 1977;42:4s.
35. Hanania EG, KavanghaJ, Hortobaghi G, Giles RE, Champlin R, Deisseroth AB: Recent advances in the application of gene therapy to human disease. Am J Med 1995;99:537-552.
36. Rothwell NJ: Cytokines and acute neurodegeneration. Mol Psychiatry 1997;2:120-121.
37. Poole S: Therapeutic application of anti-cytokine strategies. Mol Psychiatry 1997;2:137-138.